Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0563 USD | -13.38% | 0.00% | +52.16% |
May. 02 | North American Morning Briefing : Stock Futures -2- | DJ |
Apr. 25 | North American Morning Briefing : More Tech -2- | DJ |
Financials (USD)
Sales 2021 | - | Sales 2022 | - | Capitalization | 8.59M |
---|---|---|---|---|---|
Net income 2021 | -17M | Net income 2022 | -19M | EV / Sales 2021 | - |
Net cash position 2021 | 23.78M | Net cash position 2022 | 6.72M | EV / Sales 2022 | - |
P/E ratio 2021 |
-1.66
x | P/E ratio 2022 |
-0.43
x | Employees | 18 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 84.97% |
Latest transcript on Bellerophon Therapeutics, Inc.
1 day | -13.38% | ||
Current month | +2.18% | ||
1 month | +10.18% | ||
3 months | +5.23% | ||
6 months | +70.61% | ||
Current year | +52.16% |
Managers | Title | Age | Since |
---|---|---|---|
Craig Jalbert
CEO | Chief Executive Officer | 63 | - |
Martin Dekker
CTO | Chief Tech/Sci/R&D Officer | 51 | 15-01-28 |
Edwin L. Parsley
CTO | Chief Tech/Sci/R&D Officer | 63 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Naseem Amin
CHM | Chairman | 62 | 15-06-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-22 | 0.0563 | -13.38% | 5,126 |
24-05-21 | 0.065 | +4.03% | 49,121 |
24-05-20 | 0.0625 | +9.61% | 6,438 |
24-05-17 | 0.057 | +0.53% | 430 |
24-05-16 | 0.0567 | +0.71% | 3,073 |
Delayed Quote OTC Markets, May 22, 2024 at 02:41 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+52.16% | 689K | |
+9.99% | 115B | |
+12.01% | 106B | |
-3.07% | 24.69B | |
-1.08% | 21.97B | |
-5.24% | 19.27B | |
-6.90% | 17.56B | |
-39.36% | 17.32B | |
+5.82% | 14.03B | |
+33.05% | 12.13B |
- Stock Market
- Equities
- BLPH Stock